{"date":"2025-08-13","count":72,"source":"公開資訊觀測站（MOPS）","attribution":"引用請註明：Drugnews 事實帳本（https://drugnews.com.tw/filings/）與公開資訊觀測站原始公告","records":[{"id":"tw-6949-2025-08-13-1933-1uhskx3","company_id":"6949","company":"沛爾生醫*-創","market":"上市","industry":"生技醫療","date":"2025-08-13","time":"19:33:39","subject":"公告本公司董事會決議辦理現金增資發行新股","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：沛爾生醫*-創（6949），2025-08-13 19:33，「公告本公司董事會決議辦理現金增資發行新股」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6949-2025-08-13-1859-17up2wc","company_id":"6949","company":"沛爾生醫*-創","market":"上市","industry":"生技醫療","date":"2025-08-13","time":"18:59:57","subject":"公告本公司董事會決議員工認股權憑證轉換普通股之增資基準日","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：沛爾生醫*-創（6949），2025-08-13 18:59，「公告本公司董事會決議員工認股權憑證轉換普通股之增資基準日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7773-2025-08-13-1859-9ctlen","company_id":"7773","company":"富禾生醫","market":"興櫃","industry":"生技醫療","date":"2025-08-13","time":"18:59:32","subject":"公告本公司接獲衛生福利部通知終止「EBaT8」臨床試驗執行相關事宜(補充公告)。","clause":"第44款","fact_date":"2025-08-13","cite_as":"公開資訊觀測站重大訊息：富禾生醫（7773），2025-08-13 18:59，「公告本公司接獲衛生福利部通知終止「EBaT8」臨床試驗執行相關事宜(補充公告)。」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6949-2025-08-13-1859-242cg1","company_id":"6949","company":"沛爾生醫*-創","market":"上市","industry":"生技醫療","date":"2025-08-13","time":"18:59:31","subject":"公告本公司董事會通過114年第2季合併財務報表","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：沛爾生醫*-創（6949），2025-08-13 18:59，「公告本公司董事會通過114年第2季合併財務報表」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6949-2025-08-13-1858-rp57zs","company_id":"6949","company":"沛爾生醫*-創","market":"上市","industry":"生技醫療","date":"2025-08-13","time":"18:58:55","subject":"公告法人董事指派代表人出席114/08/13董事會","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：沛爾生醫*-創（6949），2025-08-13 18:58，「公告法人董事指派代表人出席114/08/13董事會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-3218-2025-08-13-1847-an54ok","company_id":"3218","company":"大學光","market":"上櫃","industry":"生技醫療","date":"2025-08-13","time":"18:47:36","subject":"本公司受邀參加花旗環球證券之2025Q2線上法說會議","clause":"第12款","fact_date":"2025-08-14","cite_as":"公開資訊觀測站重大訊息：大學光（3218），2025-08-13 18:47，「本公司受邀參加花旗環球證券之2025Q2線上法說會議」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6797-2025-08-13-1822-gi3647","company_id":"6797","company":"圓點奈米","market":"興櫃","industry":"生技醫療","date":"2025-08-13","time":"18:22:47","subject":"公告本公司董事會決議買回庫藏股事宜","clause":"第41款","fact_date":"2025-08-13","cite_as":"公開資訊觀測站重大訊息：圓點奈米（6797），2025-08-13 18:22，「公告本公司董事會決議買回庫藏股事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6797-2025-08-13-1807-1og4xto","company_id":"6797","company":"圓點奈米","market":"興櫃","industry":"生技醫療","date":"2025-08-13","time":"18:07:41","subject":"公告本公司董事會通過114年第二季財務報表","clause":"第43款","fact_date":"2025-08-13","cite_as":"公開資訊觀測站重大訊息：圓點奈米（6797），2025-08-13 18:07，「公告本公司董事會通過114年第二季財務報表」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6976-2025-08-13-1805-l3t4rn","company_id":"6976","company":"育世博-KY","market":"興櫃","industry":"生技醫療","date":"2025-08-13","time":"18:05:13","subject":"公告本公司董事會通過114年第二季合併財務報告(更正主旨:通過年度誤植為113年，更正為114年)","clause":"第43款","fact_date":"2025-08-13","cite_as":"公開資訊觀測站重大訊息：育世博-KY（6976），2025-08-13 18:05，「公告本公司董事會通過114年第二季合併財務報告(更正主旨:通過年度誤植為113年，更正為114年)」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6676-2025-08-13-1802-1uhskx3","company_id":"6676","company":"祥翊","market":"興櫃","industry":"生技醫療","date":"2025-08-13","time":"18:02:47","subject":"公告本公司董事會決議辦理現金增資發行新股","clause":"第9款","fact_date":"2025-08-13","cite_as":"公開資訊觀測站重大訊息：祥翊（6676），2025-08-13 18:02，「公告本公司董事會決議辦理現金增資發行新股」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6676-2025-08-13-1801-84656m","company_id":"6676","company":"祥翊","market":"興櫃","industry":"生技醫療","date":"2025-08-13","time":"18:01:18","subject":"公告本公司董事會通過內部稽核主管任命案","clause":"第11款","fact_date":"2025-08-13","cite_as":"公開資訊觀測站重大訊息：祥翊（6676），2025-08-13 18:01，「公告本公司董事會通過內部稽核主管任命案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6676-2025-08-13-1759-5rax5d","company_id":"6676","company":"祥翊","market":"興櫃","industry":"生技醫療","date":"2025-08-13","time":"17:59:36","subject":"公告本公司董事會決議員工認股權憑證轉換普通股增資基準日","clause":"第9款","fact_date":"2025-08-13","cite_as":"公開資訊觀測站重大訊息：祥翊（6676），2025-08-13 17:59，「公告本公司董事會決議員工認股權憑證轉換普通股增資基準日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6676-2025-08-13-1756-1xtjtmq","company_id":"6676","company":"祥翊","market":"興櫃","industry":"生技醫療","date":"2025-08-13","time":"17:56:23","subject":"公告本公司董事會通過114年第二季財務報告","clause":"第43款","fact_date":"2025-08-13","cite_as":"公開資訊觀測站重大訊息：祥翊（6676），2025-08-13 17:56，「公告本公司董事會通過114年第二季財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7850-2025-08-13-1740-xyhazt","company_id":"7850","company":"寶泰生醫","market":"興櫃","industry":"生技醫療","date":"2025-08-13","time":"17:40:05","subject":"公告本公司董事會通過114年第二季合併財務報告","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：寶泰生醫（7850），2025-08-13 17:40，「公告本公司董事會通過114年第二季合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6976-2025-08-13-1731-1uop06l","company_id":"6976","company":"育世博-KY","market":"興櫃","industry":"生技醫療","date":"2025-08-13","time":"17:31:34","subject":"代重要子公司育世博生物科技(股)公司公告決議辦理現金增資","clause":"第9款","fact_date":"2025-08-13","cite_as":"公開資訊觀測站重大訊息：育世博-KY（6976），2025-08-13 17:31，「代重要子公司育世博生物科技(股)公司公告決議辦理現金增資」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6976-2025-08-13-1731-sb4hro","company_id":"6976","company":"育世博-KY","market":"興櫃","industry":"生技醫療","date":"2025-08-13","time":"17:31:15","subject":"公告本公司董事會通過增資100%子公司育世博生物科技(股)公司","clause":"第17款","fact_date":"2025-08-13","cite_as":"公開資訊觀測站重大訊息：育世博-KY（6976），2025-08-13 17:31，「公告本公司董事會通過增資100%子公司育世博生物科技(股)公司」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4137-2025-08-13-1730-87qz4w","company_id":"4137","company":"麗豐-KY","market":"上市","industry":"生技醫療","date":"2025-08-13","time":"17:30:17","subject":"公告本公司114年第二季合併財務報告董事會召開日期","clause":"第31款","fact_date":"2025-08-13","cite_as":"公開資訊觀測站重大訊息：麗豐-KY（4137），2025-08-13 17:30，「公告本公司114年第二季合併財務報告董事會召開日期」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6976-2025-08-13-1724-1epbuv8","company_id":"6976","company":"育世博-KY","market":"興櫃","industry":"生技醫療","date":"2025-08-13","time":"17:24:09","subject":"公告本公司董事會通過113年第二季合併財務報告","clause":"第43款","fact_date":"2025-08-13","cite_as":"公開資訊觀測站重大訊息：育世博-KY（6976），2025-08-13 17:24，「公告本公司董事會通過113年第二季合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6976-2025-08-13-1723-1sscpnj","company_id":"6976","company":"育世博-KY","market":"興櫃","industry":"生技醫療","date":"2025-08-13","time":"17:23:05","subject":"公告本公司董事會決議註銷限制員工權利新股減資基準日","clause":"第9款","fact_date":"2025-08-13","cite_as":"公開資訊觀測站重大訊息：育世博-KY（6976），2025-08-13 17:23，「公告本公司董事會決議註銷限制員工權利新股減資基準日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7814-2025-08-13-1714-mkfxr3","company_id":"7814","company":"海昌生技","market":"上櫃","industry":"生技醫療","date":"2025-08-13","time":"17:14:33","subject":"更正本公司113年第4季與114年第2季IFRSs iXBRL公告資訊，更正之申報資訊對本公司營業利益及稅(前)後淨利並無影響。","clause":"第44款","fact_date":"2025-08-13","cite_as":"公開資訊觀測站重大訊息：海昌生技（7814），2025-08-13 17:14，「更正本公司113年第4季與114年第2季IFRSs iXBRL公告資訊，更正之申報資訊對本公司營業利益及稅(前)後淨利並」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6523-2025-08-13-1700-13bqai2","company_id":"6523","company":"達爾膚","market":"上櫃","industry":"生技醫療","date":"2025-08-13","time":"17:00:07","subject":"本公司董事會決議股利分派","clause":"第14款","fact_date":"2025-08-13","cite_as":"公開資訊觀測站重大訊息：達爾膚（6523），2025-08-13 17:00，「本公司董事會決議股利分派」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6523-2025-08-13-1659-aa2zln","company_id":"6523","company":"達爾膚","market":"上櫃","industry":"生技醫療","date":"2025-08-13","time":"16:59:27","subject":"公告本公司董事會通過114年第2季合併財務報告","clause":"第31款","fact_date":"2025-08-13","cite_as":"公開資訊觀測站重大訊息：達爾膚（6523），2025-08-13 16:59，「公告本公司董事會通過114年第2季合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6634-2025-08-13-1659-19n2vjo","company_id":"6634","company":"欣耀","market":"興櫃","industry":"生技醫療","date":"2025-08-13","time":"16:59:02","subject":"公告本公司董事會決議發行一一四年第一次員工認股權憑證","clause":"第9款","fact_date":"2025-08-13","cite_as":"公開資訊觀測站重大訊息：欣耀（6634），2025-08-13 16:59，「公告本公司董事會決議發行一一四年第一次員工認股權憑證」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6523-2025-08-13-1658-dgpq5s","company_id":"6523","company":"達爾膚","market":"上櫃","industry":"生技醫療","date":"2025-08-13","time":"16:58:39","subject":"公告本公司發言人、財務主管、會計主管暨公司治理主管異動","clause":"第8款","fact_date":"2025-08-13","cite_as":"公開資訊觀測站重大訊息：達爾膚（6523），2025-08-13 16:58，「公告本公司發言人、財務主管、會計主管暨公司治理主管異動」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6634-2025-08-13-1658-1vdwe7l","company_id":"6634","company":"欣耀","market":"興櫃","industry":"生技醫療","date":"2025-08-13","time":"16:58:30","subject":"公告董事會決議辦理限制員工權利新股收回註銷減資事宜","clause":"第9款","fact_date":"2025-08-13","cite_as":"公開資訊觀測站重大訊息：欣耀（6634），2025-08-13 16:58，「公告董事會決議辦理限制員工權利新股收回註銷減資事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6634-2025-08-13-1658-1xtjtmq","company_id":"6634","company":"欣耀","market":"興櫃","industry":"生技醫療","date":"2025-08-13","time":"16:58:04","subject":"公告本公司董事會通過114年第二季財務報告","clause":"第43款","fact_date":"2025-08-13","cite_as":"公開資訊觀測站重大訊息：欣耀（6634），2025-08-13 16:58，「公告本公司董事會通過114年第二季財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4106-2025-08-13-1649-3pi6d4","company_id":"4106","company":"雃博","market":"上市","industry":"生技醫療","date":"2025-08-13","time":"16:49:18","subject":"公告114年6月合併營收更正","clause":"第51款","fact_date":"2025-08-13","cite_as":"公開資訊觀測站重大訊息：雃博（4106），2025-08-13 16:49，「公告114年6月合併營收更正」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4106-2025-08-13-1648-1hi5om0","company_id":"4106","company":"雃博","market":"上市","industry":"生技醫療","date":"2025-08-13","time":"16:48:29","subject":"公告本公司民國114年度第二季合併財務報告業經提報董事會","clause":"第31款","fact_date":"2025-08-13","cite_as":"公開資訊觀測站重大訊息：雃博（4106），2025-08-13 16:48，「公告本公司民國114年度第二季合併財務報告業經提報董事會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6586-2025-08-13-1646-1o6ud9n","company_id":"6586","company":"醣基","market":"興櫃","industry":"生技醫療","date":"2025-08-13","time":"16:46:08","subject":"公告本公司董事會追認修訂114年第1次員工認股權憑證發行及認股辦法","clause":"第9款","fact_date":"2025-08-13","cite_as":"公開資訊觀測站重大訊息：醣基（6586），2025-08-13 16:46，「公告本公司董事會追認修訂114年第1次員工認股權憑證發行及認股辦法」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6586-2025-08-13-1645-5rh607","company_id":"6586","company":"醣基","market":"興櫃","industry":"生技醫療","date":"2025-08-13","time":"16:45:32","subject":"公告本公司董事會決議解除經理人競業禁止之限制","clause":"第22款","fact_date":"2025-08-13","cite_as":"公開資訊觀測站重大訊息：醣基（6586），2025-08-13 16:45，「公告本公司董事會決議解除經理人競業禁止之限制」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6973-2025-08-13-1645-muluxb","company_id":"6973","company":"永立榮","market":"興櫃","industry":"生技醫療","date":"2025-08-13","time":"16:45:28","subject":"公告本公司董事會決議通過114年第二季合併財務報告","clause":"第43款","fact_date":"2025-08-13","cite_as":"公開資訊觀測站重大訊息：永立榮（6973），2025-08-13 16:45，「公告本公司董事會決議通過114年第二季合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6586-2025-08-13-1644-y2lqg0","company_id":"6586","company":"醣基","market":"興櫃","industry":"生技醫療","date":"2025-08-13","time":"16:44:55","subject":"董事會決議114年度第2季不發放股利","clause":"第31款","fact_date":"2025-08-13","cite_as":"公開資訊觀測站重大訊息：醣基（6586），2025-08-13 16:44，「董事會決議114年度第2季不發放股利」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6576-2025-08-13-1644-1bjcuf","company_id":"6576","company":"逸達","market":"上櫃","industry":"生技醫療","date":"2025-08-13","time":"16:44:41","subject":"本公司董事會決議通過114年第2季合併財務報告","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：逸達（6576），2025-08-13 16:44，「本公司董事會決議通過114年第2季合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6586-2025-08-13-1644-e7i9dp","company_id":"6586","company":"醣基","market":"興櫃","industry":"生技醫療","date":"2025-08-13","time":"16:44:20","subject":"公告本公司董事會通過114年度第2季合併財務報告","clause":"第43款","fact_date":"2025-08-13","cite_as":"公開資訊觀測站重大訊息：醣基（6586），2025-08-13 16:44，「公告本公司董事會通過114年度第2季合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4120-2025-08-13-1640-1sede3a","company_id":"4120","company":"友華","market":"上櫃","industry":"生技醫療","date":"2025-08-13","time":"16:40:49","subject":"(更正114/08/13序號1重訊主旨)公告本公司董事會決議通過114年度第二季合併財務報告","clause":"第31款","fact_date":"2025-08-13","cite_as":"公開資訊觀測站重大訊息：友華（4120），2025-08-13 16:40，「(更正114/08/13序號1重訊主旨)公告本公司董事會決議通過114年度第二季合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4116-2025-08-13-1640-1kagp3s","company_id":"4116","company":"明基醫","market":"上櫃","industry":"生技醫療","date":"2025-08-13","time":"16:40:27","subject":"公告補充本公司113年度年報部分內容","clause":"第50款","fact_date":"2025-08-13","cite_as":"公開資訊觀測站重大訊息：明基醫（4116），2025-08-13 16:40，「公告補充本公司113年度年報部分內容」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7814-2025-08-13-1637-mkfxr3","company_id":"7814","company":"海昌生技","market":"上櫃","industry":"生技醫療","date":"2025-08-13","time":"16:37:31","subject":"更正本公司113年第4季與114年第2季IFRSs iXBRL公告資訊，更正之申報資訊對本公司營業利益及稅(前)後淨利並無影響。","clause":"第44款","fact_date":"2025-08-13","cite_as":"公開資訊觀測站重大訊息：海昌生技（7814），2025-08-13 16:37，「更正本公司113年第4季與114年第2季IFRSs iXBRL公告資訊，更正之申報資訊對本公司營業利益及稅(前)後淨利並」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6808-2025-08-13-1636-1xtjtmq","company_id":"6808","company":"三鼎生技","market":"興櫃","industry":"生技醫療","date":"2025-08-13","time":"16:36:28","subject":"公告本公司董事會通過114年第二季財務報告","clause":"第43款","fact_date":"2025-08-13","cite_as":"公開資訊觀測站重大訊息：三鼎生技（6808），2025-08-13 16:36，「公告本公司董事會通過114年第二季財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6808-2025-08-13-1636-17v9sbz","company_id":"6808","company":"三鼎生技","market":"興櫃","industry":"生技醫療","date":"2025-08-13","time":"16:36:05","subject":"公告本公司董事會追認修訂114年限制員工權利新股發行辦法","clause":"第9款","fact_date":"2025-08-13","cite_as":"公開資訊觀測站重大訊息：三鼎生技（6808），2025-08-13 16:36，「公告本公司董事會追認修訂114年限制員工權利新股發行辦法」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6808-2025-08-13-1635-kqbnnn","company_id":"6808","company":"三鼎生技","market":"興櫃","industry":"生技醫療","date":"2025-08-13","time":"16:35:34","subject":"公告本公司董事會通過追認新任業務部副總經理暨總經理異動","clause":"第6款","fact_date":"2025-08-13","cite_as":"公開資訊觀測站重大訊息：三鼎生技（6808），2025-08-13 16:35，「公告本公司董事會通過追認新任業務部副總經理暨總經理異動」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4120-2025-08-13-1634-1kzjq9","company_id":"4120","company":"友華","market":"上櫃","industry":"生技醫療","date":"2025-08-13","time":"16:34:45","subject":"公告本公司董事會決議通過114年度第一季合併財務報告","clause":"第31款","fact_date":"2025-08-13","cite_as":"公開資訊觀測站重大訊息：友華（4120），2025-08-13 16:34，「公告本公司董事會決議通過114年度第一季合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6572-2025-08-13-1617-140kqs7","company_id":"6572","company":"博錸","market":"興櫃","industry":"生技醫療","date":"2025-08-13","time":"16:17:15","subject":"公告本公司董事會通過114年度第二季合併財務報告","clause":"第43款","fact_date":"2025-08-13","cite_as":"公開資訊觀測站重大訊息：博錸（6572），2025-08-13 16:17，「公告本公司董事會通過114年度第二季合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6598-2025-08-13-1606-1t3n6rv","company_id":"6598","company":"ABC-KY","market":"上市","industry":"生技醫療","date":"2025-08-13","time":"16:06:51","subject":"公告114年第二季財務報告董事會召開日期","clause":"第31款","fact_date":"2025-08-13","cite_as":"公開資訊觀測站重大訊息：ABC-KY（6598），2025-08-13 16:06，「公告114年第二季財務報告董事會召開日期」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6527-2025-08-13-1603-1lmv9jb","company_id":"6527","company":"明達醫","market":"上櫃","industry":"生技醫療","date":"2025-08-13","time":"16:03:39","subject":"公告補正本公司113年度股東會年報部分內容","clause":"第50款","fact_date":"2025-08-13","cite_as":"公開資訊觀測站重大訊息：明達醫（6527），2025-08-13 16:03，「公告補正本公司113年度股東會年報部分內容」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6615-2025-08-13-1600-1jfvhev","company_id":"6615","company":"慧智","market":"上櫃","industry":"生技醫療","date":"2025-08-13","time":"16:00:36","subject":"公告本公司新增資金貸與金額達新臺幣一千萬元以上且達本公司最近期財務報表淨值百分之二以上","clause":"第23款","fact_date":"2025-08-13","cite_as":"公開資訊觀測站重大訊息：慧智（6615），2025-08-13 16:00，「公告本公司新增資金貸與金額達新臺幣一千萬元以上且達本公司最近期財務報表淨值百分之二以上」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6615-2025-08-13-1559-1jfvhev","company_id":"6615","company":"慧智","market":"上櫃","industry":"生技醫療","date":"2025-08-13","time":"15:59:33","subject":"公告本公司新增資金貸與金額達新臺幣一千萬元以上且達本公司最近期財務報表淨值百分之二以上","clause":"第23款","fact_date":"2025-08-13","cite_as":"公開資訊觀測站重大訊息：慧智（6615），2025-08-13 15:59，「公告本公司新增資金貸與金額達新臺幣一千萬元以上且達本公司最近期財務報表淨值百分之二以上」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-3218-2025-08-13-1557-xyhazt","company_id":"3218","company":"大學光","market":"上櫃","industry":"生技醫療","date":"2025-08-13","time":"15:57:17","subject":"公告本公司董事會通過114年第二季合併財務報告","clause":"第31款","fact_date":"2025-08-13","cite_as":"公開資訊觀測站重大訊息：大學光（3218），2025-08-13 15:57，「公告本公司董事會通過114年第二季合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6615-2025-08-13-1556-140kqs7","company_id":"6615","company":"慧智","market":"上櫃","industry":"生技醫療","date":"2025-08-13","time":"15:56:16","subject":"公告本公司董事會通過114年度第二季合併財務報告","clause":"第31款","fact_date":"2025-08-13","cite_as":"公開資訊觀測站重大訊息：慧智（6615），2025-08-13 15:56，「公告本公司董事會通過114年度第二季合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6932-2025-08-13-1541-xyhazt","company_id":"6932","company":"水星生醫*","market":"興櫃","industry":"生技醫療","date":"2025-08-13","time":"15:41:14","subject":"公告本公司董事會通過114年第二季合併財務報告","clause":"第43款","fact_date":"2025-08-13","cite_as":"公開資訊觀測站重大訊息：水星生醫*（6932），2025-08-13 15:41，「公告本公司董事會通過114年第二季合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4170-2025-08-13-1534-muluxb","company_id":"4170","company":"鑫品生醫","market":"興櫃","industry":"生技醫療","date":"2025-08-13","time":"15:34:26","subject":"公告本公司董事會決議通過114年第二季合併財務報告","clause":"第43款","fact_date":"2025-08-13","cite_as":"公開資訊觀測站重大訊息：鑫品生醫（4170），2025-08-13 15:34，「公告本公司董事會決議通過114年第二季合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1731-2025-08-13-1532-1116gu6","company_id":"1731","company":"美吾華","market":"上市","industry":"生技醫療","date":"2025-08-13","time":"15:32:55","subject":"公告本公司董事會通過公司治理主管及財會主管異動","clause":"第8款","fact_date":"2025-08-13","cite_as":"公開資訊觀測站重大訊息：美吾華（1731），2025-08-13 15:32，「公告本公司董事會通過公司治理主管及財會主管異動」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4732-2025-08-13-1530-61p8d8","company_id":"4732","company":"彥臣","market":"興櫃","industry":"生技醫療","date":"2025-08-13","time":"15:30:13","subject":"本公司依公開發行公司資金貸與背書保證處理準則第二十二條第一項第三款之規定辦理公告","clause":"第20款","fact_date":"2025-08-13","cite_as":"公開資訊觀測站重大訊息：彥臣（4732），2025-08-13 15:30，「本公司依公開發行公司資金貸與背書保證處理準則第二十二條第一項第三款之規定辦理公告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-3176-2025-08-13-1529-wet4zf","company_id":"3176","company":"基亞","market":"上櫃","industry":"生技醫療","date":"2025-08-13","time":"15:29:51","subject":"代重要子公司TBG Diagnostics Ltd.公告董事改選當選名單","clause":"第6款","fact_date":"2025-08-13","cite_as":"公開資訊觀測站重大訊息：基亞（3176），2025-08-13 15:29，「代重要子公司TBG Diagnostics Ltd.公告董事改選當選名單」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6612-2025-08-13-1527-1xnu34j","company_id":"6612","company":"奈米醫材","market":"上櫃","industry":"生技醫療","date":"2025-08-13","time":"15:27:11","subject":"本公司受邀參加櫃買中心業績發表會","clause":"第12款","fact_date":"2025-08-26","cite_as":"公開資訊觀測站重大訊息：奈米醫材（6612），2025-08-13 15:27，「本公司受邀參加櫃買中心業績發表會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6666-2025-08-13-1520-1tkkj4d","company_id":"6666","company":"羅麗芬-KY","market":"上市","industry":"生技醫療","date":"2025-08-13","time":"15:20:53","subject":"公告本公司114年第二季財務報告董事會召開日期","clause":"第31款","fact_date":"2025-08-13","cite_as":"公開資訊觀測站重大訊息：羅麗芬-KY（6666），2025-08-13 15:20，「公告本公司114年第二季財務報告董事會召開日期」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4105-2025-08-13-1518-j5kfqh","company_id":"4105","company":"東洋","market":"上櫃","industry":"生技醫療","date":"2025-08-13","time":"15:18:46","subject":"本公司受邀參加國泰證券舉辦之線上法人說明會","clause":"第12款","fact_date":"2025-08-20","cite_as":"公開資訊觀測站重大訊息：東洋（4105），2025-08-13 15:18，「本公司受邀參加國泰證券舉辦之線上法人說明會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4732-2025-08-13-1512-w4w18m","company_id":"4732","company":"彥臣","market":"興櫃","industry":"生技醫療","date":"2025-08-13","time":"15:12:23","subject":"公告本公司提報董事會114年度第二季合併財務報告","clause":"第43款","fact_date":"2025-08-13","cite_as":"公開資訊觀測站重大訊息：彥臣（4732），2025-08-13 15:12，「公告本公司提報董事會114年度第二季合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7759-2025-08-13-1507-1p3d51","company_id":"7759","company":"視航生醫","market":"興櫃","industry":"生技醫療","date":"2025-08-13","time":"15:07:57","subject":"公告本公司董事會決議通過114年第2季合併財務報告","clause":"第43款","fact_date":"2025-08-13","cite_as":"公開資訊觀測站重大訊息：視航生醫（7759），2025-08-13 15:07，「公告本公司董事會決議通過114年第2季合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4724-2025-08-13-1505-w4w18m","company_id":"4724","company":"宣捷幹細胞","market":"興櫃","industry":"生技醫療","date":"2025-08-13","time":"15:05:25","subject":"公告本公司提報董事會114年度第二季合併財務報告","clause":"第43款","fact_date":"2025-08-13","cite_as":"公開資訊觀測站重大訊息：宣捷幹細胞（4724），2025-08-13 15:05，「公告本公司提報董事會114年度第二季合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-3205-2025-08-13-1502-aa2zln","company_id":"3205","company":"佰研","market":"上櫃","industry":"生技醫療","date":"2025-08-13","time":"15:02:33","subject":"公告本公司董事會通過114年第2季合併財務報告","clause":"第31款","fact_date":"2025-08-13","cite_as":"公開資訊觀測站重大訊息：佰研（3205），2025-08-13 15:02，「公告本公司董事會通過114年第2季合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6872-2025-08-13-1500-xyhazt","company_id":"6872","company":"浩宇生醫","market":"上櫃","industry":"生技醫療","date":"2025-08-13","time":"15:00:45","subject":"公告本公司董事會通過114年第二季合併財務報告","clause":"第31款","fact_date":"2025-08-13","cite_as":"公開資訊觀測站重大訊息：浩宇生醫（6872），2025-08-13 15:00，「公告本公司董事會通過114年第二季合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4168-2025-08-13-1456-140kqs7","company_id":"4168","company":"醣聯","market":"上櫃","industry":"生技醫療","date":"2025-08-13","time":"14:56:07","subject":"公告本公司董事會通過114年度第二季合併財務報告","clause":"第31款","fact_date":"2025-08-13","cite_as":"公開資訊觀測站重大訊息：醣聯（4168），2025-08-13 14:56，「公告本公司董事會通過114年度第二季合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6931-2025-08-13-1447-1qpfaa0","company_id":"6931","company":"青松健康","market":"上市","industry":"生技醫療","date":"2025-08-13","time":"14:47:46","subject":"本公司董事會通過設置永續發展委員會及委任委員會成員","clause":"第6款","fact_date":"2025-08-13","cite_as":"公開資訊觀測站重大訊息：青松健康（6931），2025-08-13 14:47，「本公司董事會通過設置永續發展委員會及委任委員會成員」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4133-2025-08-13-1447-aa2zln","company_id":"4133","company":"亞諾法","market":"上市","industry":"生技醫療","date":"2025-08-13","time":"14:47:21","subject":"公告本公司董事會通過114年第2季合併財務報告","clause":"第31款","fact_date":"2025-08-13","cite_as":"公開資訊觀測站重大訊息：亞諾法（4133），2025-08-13 14:47，「公告本公司董事會通過114年第2季合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6931-2025-08-13-1447-1kufjq8","company_id":"6931","company":"青松健康","market":"上市","industry":"生技醫療","date":"2025-08-13","time":"14:47:18","subject":"公告本公司副總經理晉升案","clause":"第8款","fact_date":"2025-08-13","cite_as":"公開資訊觀測站重大訊息：青松健康（6931），2025-08-13 14:47，「公告本公司副總經理晉升案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6931-2025-08-13-1446-bj1ciz","company_id":"6931","company":"青松健康","market":"上市","industry":"生技醫療","date":"2025-08-13","time":"14:46:54","subject":"本公司董事會決議分派114年第二季盈餘","clause":"第14款","fact_date":"2025-08-13","cite_as":"公開資訊觀測站重大訊息：青松健康（6931），2025-08-13 14:46，「本公司董事會決議分派114年第二季盈餘」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6931-2025-08-13-1442-xyhazt","company_id":"6931","company":"青松健康","market":"上市","industry":"生技醫療","date":"2025-08-13","time":"14:42:37","subject":"公告本公司董事會通過114年第二季合併財務報告","clause":"第31款","fact_date":"2025-08-13","cite_as":"公開資訊觀測站重大訊息：青松健康（6931），2025-08-13 14:42，「公告本公司董事會通過114年第二季合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6934-2025-08-13-1405-knofar","company_id":"6934","company":"心誠鎂","market":"上市","industry":"生技醫療","date":"2025-08-13","time":"14:05:31","subject":"公告本公司董事會通過114年第二季合併財務報告案","clause":"第43款","fact_date":"2025-08-13","cite_as":"公開資訊觀測站重大訊息：心誠鎂（6934），2025-08-13 14:05，「公告本公司董事會通過114年第二季合併財務報告案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6712-2025-08-13-1403-15976m1","company_id":"6712","company":"長聖","market":"上櫃","industry":"生技醫療","date":"2025-08-13","time":"14:03:15","subject":"公告更正本公司114年第二季XBRL資訊合併財務報告部分資訊","clause":"第53款","fact_date":"2025-08-13","cite_as":"公開資訊觀測站重大訊息：長聖（6712），2025-08-13 14:03，「公告更正本公司114年第二季XBRL資訊合併財務報告部分資訊」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-3176-2025-08-13-1357-10uoibe","company_id":"3176","company":"基亞","market":"上櫃","industry":"生技醫療","date":"2025-08-13","time":"13:57:54","subject":"代重要子公司TBG Diagnostics Ltd.公告股東會決議事項","clause":"第18款","fact_date":"2025-08-13","cite_as":"公開資訊觀測站重大訊息：基亞（3176），2025-08-13 13:57，「代重要子公司TBG Diagnostics Ltd.公告股東會決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1731-2025-08-13-1350-aa2zln","company_id":"1731","company":"美吾華","market":"上市","industry":"生技醫療","date":"2025-08-13","time":"13:50:53","subject":"公告本公司董事會通過114年第2季合併財務報告","clause":"第31款","fact_date":"2025-08-13","cite_as":"公開資訊觀測站重大訊息：美吾華（1731），2025-08-13 13:50，「公告本公司董事會通過114年第2季合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6892-2025-08-13-0659-1o1zh9g","company_id":"6892","company":"台寶生醫","market":"興櫃","industry":"生技醫療","date":"2025-08-13","time":"06:59:25","subject":"本集團與美國TRACT THERAPEUTICS, INC.簽訂併購合約","clause":"第8款","fact_date":"2025-08-13","cite_as":"公開資訊觀測站重大訊息：台寶生醫（6892），2025-08-13 06:59，「本集團與美國TRACT THERAPEUTICS, INC.簽訂併購合約」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"}]}